CI

At a glance

ClinicalIndex Comparison Record
Phase 2Active· 48 enrolled
Drug / intervention
Cognitive Behavior Therapy +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03747757
NCT03747757Phase 2Active

Cognitive Behavioral Therapy (CBT) Intervention for Cancer Related Fatigue (CRF) in Patients With AML and Lymphoma

M.D. Anderson Cancer Center·interventional·Posted Nov 20, 2018·Updated May 20, 2026

In Brief

A Phase 2 clinical trial evaluating Cognitive Behavior Therapy, Quality-of-Life Assessment, and 1 other intervention for Acute Myeloid Leukemia and 4 related conditions. Active but no longer recruiting, targeting 48 participants across 1 site.

Detailed Summary

This trial studies how well cognitive behavioral therapy works in helping patients with acute myeloid leukemia or lymphoma with cancer-related fatigue. Behavioral therapy uses methods to help patients change the way they think and act. Behavioral skills may help patients with acute myeloid leukemia or lymphoma cope with anxiety, depression, and other factors that may influence their level of cancer-related fatigue.

Study Details

Timeline

Phase 2Active
201920202021202220232024202520262027
First PostedNov 20, 2018
Enrollment StartNov 29, 2018
Primary CompletionSep 11, 2027
TodayJul 1, 2026
Enrollment to primary: 8.8 yearsPosted 7.6 years agoPrimary completion in 1.2 years

Interventions

Cognitive Behavior Therapybehavioral

Undergo CBT

Quality-of-Life Assessmentother

Ancillary studies

Questionnaire Administrationother

Ancillary studies